Emerging concepts in outcome assessment for COPD clinical trials

Seminars in Respiratory and Critical Care Medicine

Volumn 26, Issue 2, 2005, Pages 253-262

  Patel, Sanjay A ^a   Sciurba, Frank C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

COPD; Exercise testing; Outcome assessment

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYCLING; DAILY LIFE ACTIVITY; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CAPACITY; MEASUREMENT; OUTCOMES RESEARCH; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; REPRODUCIBILITY; REVIEW; VALIDATION PROCESS; WALKING;

BRONCHODILATOR AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; VITAL CAPACITY;

EID: 18144426384     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-869544     Document Type: Review

References (123)

1. Mannino D, Homma D, Akinbami L, et al. Chronic Obstructive Pulmonary Disease Surveillance: United States, 1971-2000. Hyattsville, MD: National Center for Health Statistics; 2000
2. Michaud CM, Murray CJ, Bloom BR. Burden of disease: implications for future research. JAMA 2001;285:535-539
3. Lopez A, Murray C. The global burden of disease 1990-2000. Nat Med 1998;4:1241-1243
4. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5S-9S
5. Barnes PJ. New treatments for COPD. Nat Rev Drug Discov 2002;1:437-446
6. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19:217-224
7. Kilfeather S. 5-lipoxygenase inhibitors for the treatment of COPD. Chest 2002;121:197S-200S
8. De Boer WI. Cytokines and therapy in COPD: a promising combination? Chest 2002;121:209S-218S
9. MacNee W. Oxidants/antioxidants and COPD. Chest 2000;117:303S-317S
10. Compton CH, Gubb J, Nieman R, et al. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet 2001;358:265-270
11. Fujie K, Shinguh Y, Inamura N, et al. Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, FR134043. Eur J Pharmacol 1999;374:117-125
12. Mao JT, Goldin JG, Dermand J, et al. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med 2002;165:718-723
13. Croxton TL, Weinmann GG, Senior RM, Hoidal JR. Future research directions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;165:838-844
14. Fishman AP. Pulmonary rehabilitation research. Am J Respir Crit Care Med 1994;149:825-833
15. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985;38:517-524
16. Fink G, Moshe S, Goshen J, et al. Functional evaluation in patients with chronic obstructive pulmonary disease: pulmonary function test versus cardiopulmonary exercise test. J Occup Environ Med 2002;44:54-58
17. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-39
18. Wolkove N, Dajczman E, Colacone A, Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1989;96:1247-1251
19. Gorkin L, Norvell NK, Rosen RC, et al. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol 1993;71:1069-1073
20. Mahler DA, Harver A. Prediction of peak oxygen consumption in obstructive airway disease. Med Sci Sports Exerc 1988;20:574-578
21. Matthews JI, Bush BA, Ewald FW. Exercise responses during incremental and high intensity and low intensity steady state exercise in patients with obstructive lung disease and normal control subjects. Chest 1989;96:11-17
22. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327
23. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073
24. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823-832
25. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 1993;148:1351-1357
26. Wasserman K, Hansen J, Sue D, et al. Principles of Exercise Testing and Interpretation. Philadelphia: Lippincott Williams St Wilkins; 1999
27. Morgan AD, Peck DF, Buchanan DR, McHardy GJ. Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis. Br Med J (Clin Res Ed) 1983;286:171-173
28. Statement ATS. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117
29. Casaburi R. Skeletal muscle function in COPD. Chest 2000;117:267S-271S
30. Donahoe M. Nutritional aspects of lung disease. Respir Care Clin N Am 1998;4:85-112
31. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151-1156
32. Schols AM, Mostert R, Soeters PB, et al. Nutritional state and exercise performance in patients with chronic obstructive lung disease. Thorax 1989;44:937-941
33. Mostert R, Goris A, Weling-Scheepers C, et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-867
34. Yoshikawa M, Yoneda T, Takenaka H, et al. Distribution of muscle mass and maximal exercise performance in patients with COPD. Chest 2001;119:93-98
35. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2807-2813
36. Palange P, Forte S, Felli A, et al. Nutritional state and exercise tolerance in patients with COPD. Chest 1995;107:1206-1212
37. Palange P, Forte S, Onorati P, et al. Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest 1998;114:12-18
38. Haccoun C, Smountas AA, Gibbons WJ, et al. Isokinetic muscle function in COPD. Chest 2002;121:1079-1084
39. Killian KJ, Summers E, Jones NL, Campbell EJ. Dyspnea and leg effort during incremental cycle ergometry. Am Rev Respir Dis 1992;145:1339-1345
40. Man WD, Soliman MG, Gearing J, et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:562-567
41. Gosker HR, Lencer NH, Franssen FM, et al. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003;123:1416-1424
42. Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:425-430
43. Jeffery Mador M, Kufel TJ, Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:447-453
44. Casaburi R, Patessio A, Ioli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991;143:9-18
45. Maltais F, Simard AA, Simard C, et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288-293
46. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485-489
47. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990;3:192-196
48. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 2002;19:617-625
49. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-1418
50. Takabatake N, Nakamura H, Abe S, et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1215-1219
51. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002;121:127S-130S
52. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119:256-270
53. McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. BMJ 1976;1:822-823
54. Butland RJ, Pang J, Gross ER, et al. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982;284:1607-1608
55. Cooper KH. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA 1968;203:201-204
56. Troosters T, Vilaro J, Rabinovich R, et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J 2002;20:564-569
57. Alison JA, Anderson SD. Comparison of two methods of assessing physical performance in patients with chronic airway obstruction. Phys Ther 1981;61:1278-1280
58. Swinburn CR, Wakefield JM, Jones PW. Performance, ventilation, and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease. Thorax 1985;40:581-586
59. Faggiano P, D'Aloia A, Gualeni A, Giordano A. Assessment of oxygen uptake during the six-minute walk test in patients with heart failure. Chest 1997;111:1146
60. Riley M, McParland J, Stanford CF, Nicholls DP. Oxygen consumption during corridor walk testing in chronic cardiac failure. Eur Heart J 1992;13:789-793
61. Onorati P, Antonucci R, Valli G, et al. Noninvasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 2003;89:331-336
62. Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-1024
63. Singh SJ, Morgan MD, Hardman AE, et al. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 1994;7:2016-2020
64. Revill SM, Morgan MD, Singh SJ, et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-222
65. Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992;45:1341-1345
66. Kessler R, Faller M, Fourgaut G, et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:158-164
67. Oga T, Nishimura K, Tsukino M, et al. Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease. Heart Lung 2002;31:374-381
68. Elpern EH, Stevens D, Kesten S. Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest 2000;118:98-105
69. Brown SE, Wiener S, Brown RA, et al. Exercise performance following a carbohydrate load in chronic airflow obstruction. J Appl Physiol 1985;58:1340-1346
70. Sciurba F, Criner GJ, Lee SM, et al. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003;167:1522-1527
71. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984;39:818-822
72. Noseda A, Carpiaux JP, Prigogine T, Schmerber J. Lung function, maximum and submaxinum exercise testing in COPD patients: reproducibility over a long interval. Lung 1989;167:247-257
73. Morales FJ, Montemayor T, Martinez A. Shuttle versus six-minute walk test in the prediction of outcome in chronic heart failure. Int J Cardiol 2000;76:101-105
74. Stevens D, Elpern E, Sharma K, et al. Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med 1999;160:1540-1543
75. Swerts PM, Mostert R, Wouters EF. Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease. Phys Ther 1990;70:439-442
76. Revill SM, Beck KE, Morgan MD. Comparison of the peak exercise response measured by the ramp and 1-min step cycle exercise protocols in patients with exertional dyspnea. Chest 2002;121:1099-1105
77. Parameswaran SI, Slivka WA, Bauldoff GS, Sciurba FC. Variations in cardiopulmonary exercise testing protocol affects measured outcome parameters of aerobic performance in severe COPD [abstract]. Chest 1999;116(suppl 2):332S
78. Myers J, Buchanan N, Walsh D, et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991;17:1334-1342
79. Debigare R, Maltais F, Mallet M, et al. Influence of work rate incremental rate on the exercise responses in patients with COPD. Med Sci Sports Exerc 2000;32:1365-1368
80. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115-1119
81. Leggett RJ, Flenley DC. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale. BMJ 1977;2:84-86
82. Criner GJ, Cordova FC, Furukawa S, et al. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:2018-2027
83. Pompeo E, Marino M, Nofroni I, et al. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. Ann Thorac Surg 2000;70:948-953; discussion 954
84. Liesker JJ, Wijkstra PJ, Ten Hacken NH, et al. A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD. Chest 2002;121:597-608
85. Oga T, Nishimura K, Tsukino M, et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease: a comparison of three different exercise tests. Am J Respir Crit Care Med 2000;161:1897-1901
86. Bavaria JE, Kotloff R, Palevsky H, et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1997;113:520-527; discussion 528
87. Patterson GA, Maurer JR, Williams TJ, et al. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg 1991;101:623-631; discussion 631-622
88. Sanchez Riera H, Montemayor Rubio T, Ortega Ruiz F, et al. Inspiratory muscle training in patients with COPD; effect on dyspnea, exercise performance, and quality of life. Chest 2001;120:748-756
89. Bestall JC, Paul EA, Garrod R, et al. Longitudinal trends in exercise capacity and health status after pulmonary rehabilitation in patients with COPD. Respir Med 2003;97:173-180
90. Revill SM, Singh SJ, Morgan MD. Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. Respir Med 2000;94:778-783
91. Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 2000;343:239-245
92. Morgan CJ, Singh SJ, Shah D, Morgan MDL. The sensitivity of the incremental & endurance shuttle walking tests to ambulatory oxygen [abstract]. Am J Respir Crit Care Med 2003;167:A670
93. Mador MJ, Kufel TJ, Pineda LA, et al. Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise. Am J Respir Crit Care Med 2001;163:930-935
94. Palange P, Forte S, Onorati P, et al. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 2000;88:1715-1720
95. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-549
96. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-1565
97. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:967-975
98. Szekely LA, Oelberg DA, Wright C, et al. Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. Chest 1997;111:550-558
99. Kadikar A, Maurer J, Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 1997;16:313-319
100. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993;270:1702-1707
101. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158:1384-1387
102. Ikegami Y, Hiruta S, Ikegami H, Miyamura M. Development of a telemetry system for measuring oxygen uptake during sports activities. Eur J Appl Physiol Occup Physiol 1988;57:622-626
103. Crandall CG, Taylor SL, Raven PB. Evaluation of the Cosmed K2 portable telemetric oxygen uptake analyzer. Med Sci Sports Exerc 1994;26:108-111
104. Kawakami Y, Nozaki D, Matsuo A, Fukunaga T. Reliability of measurement of oxygen uptake by a portable telemetric system. Eur J Appl Physiol Occup Physiol 1992;65:409-414
105. Novitsky S, Segal KR, Chatr-Aryamontri B, et al. Validity of a new portable indirect calorimeter: the AeroSport TEEM 100. Eur J Appl Physiol Occup Physiol 1995;70:462-467
106. Schulz H, Helle S, Heck H. The validity of the telemetric system CORTEX X1 in the ventilatory and gas exchange measurement during exercise. Int J Sports Med 1997;18:454-457
107. Melanson EL, Freedson PS, Hendelman D, Debold E. Reliability and validity of a portable metabolic measurement system. Can J Appl Physiol 1996;21:109-119
108. Casaburi R, Barstow TJ, Robinson T, Wasserman K. Influence of work rate on ventilatory and gas exchange kinetics. J Appl Physiol 1989;67:547-555
109. Chuang ML, Ting H, Otsuka T, et al. Muscle deoxygenation as related to work rate. Med Sci Sports Exerc 2002;34:1614-1623
110. Le Masurier GC, Tudor-Locke C. Comparison of pedometer and accelerometer accuracy under controlled conditions. Med Sci Sports Exerc 2003;35:867-871
111. Bouten CV, Westerterp KR, Verduin M, Janssen JD. Assessment of energy expenditure for physical activity using a triaxial accelerometer. Med Sci Sports Exerc 1994;26:1516-1523
112. Steele BG, Holt L, Belza B, et al. Quantitating physical activity in COPD using a triaxial accelerometer. Chest 2000;117:1359-1367
113. Bouten CV, Verboeket-van de Venne WP, Westerterp KR, et al. Daily physical activity assessment: comparison between movement registration and doubly labeled water. J Appl Physiol 1996;81:1019-1026
114. Belza B, Steele BG, Hunziker J, et al. Correlates of physical activity in chronic obstructive pulmonary disease. Nurs Res 2001;50:195-202
115. Starling RD, Matthews DE, Ades PA, Poehlman ET. Assessment of physical activity in older individuals: a doubly labeled water study. J Appl Physiol 1999;86:2090-2096
116. Chen KY, Sun M. Improving energy expenditure estimation by using a triaxial accelerometer. J Appl Physiol 1997;83:2112-2122
117. Steele BG, Belza B, Hunziker J, et al. Monitoring daily activity during pulmonary rehabilitation using a triaxial accelerometer. J Cardiopulm Rehabil 2003;23:139-142
118. Schonhofer B, Ardes P, Geibel M, et al. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997;10:2814-2819
119. Jakicic JM, Marcus M, Gallagher KI, et al. Evaluation of the SenseWear Pro Armband to assess energy expenditure during exercise. Med Sci Sports Exerc 2004;36:897-904
120. Fruin ML, Rankin JW. Validity of a multi-sensor armband in estimating rest and exercise energy expenditure. Med Sci Sports Exerc 2004;36:1063-1069
121. King GA, Torres N, Potter C, et al. Comparision of activity monitors to estimate energy cost of treadmill exercise. Med Sci Sports Exerc 2004;36:1244-1251
122. Patel SA, Slivka WA, Sciurba FC. Validation of a wearable body monitoring device in COPD. Am J Respir Crit Care Med 2004;169:A771
123. Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr. Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc 2002;34:1376-1381